Chemical Compound

Clarithromycin Impurity G

CAS Registry Number 127182-44-9
Clarithromycin Impurity G chemical structure
Primary Record

Clarithromycin Impurity G

In stock
1,343 g
Purity
98.2 %
CAS
127182-44-9

Compound Identifiers & Properties

CAS
127182-44-9
PubChem CID
71314812
SMILES
CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
Canonical SMILES
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)/C(=N\OC)[C@H](C)[C@@H](O)[C@]1(C)O

Names & Synonyms

  • Clarithromycin Impurity G
  • Clarithromycin (9E)-O-Methyloxime
  • 127182-44-9
  • Clarithromycin EP impurity G
  • SCHEMBL31384196
  • DTXSID20747349
  • IC166194
  • 6-O-Methylerythromycin (9E)-9-(O-Methyloxime)
  • NS00000787
  • (9E)-6-O-Methylerythromycin 9-(O-methyloxime
  • A899079
  • 1,1,1-trifluoro-3-pyridin-2-ylsulfanylpropan-2-one
  • 1,1,1-trifluoro-3-pyrimidin-2-ylsulfanylpropan-2-one
  • 1,1,1-trifluoro-3-quinolin-2-ylsulfanylpropan-2-one
  • 1,1,1-trifluoro-3-quinolin-8-ylsulfanylpropan-2-one
  • 1,1,1-trifluoro-3-(1H-imidazol-2-ylsulfanyl)propan-2-one
  • (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-10-methoxyimino-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
  • (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-10-(methoxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
  • 2-(3,3,3-trifluoro-2-oxopropyl)sulfanyl-5H-pyrimidin-4-one
  • 1,1,1-trifluoro-3-(1-methylimidazol-2-yl)sulfanylpropan-2-one
  • 2-(3,3,3-trifluoro-2-oxopropyl)sulfanylpyridine-3-carboxylic acid
  • 6-phenyl-2-(3,3,3-trifluoro-2-oxopropyl)sulfanyl-5H-pyrimidin-4-one
  • (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-10-methoxyimino-3,5,7,9,11,13-hexamethyl-oxacyclot
  • (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLOXAN-2-YL]OXY}-14-ETHYL-12,13-DIHYDROXY-4-{[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLOXAN-2-YL]OXY}-7-METHOXY-10-(METHOXYIMINO)-3,5,7,9,11,13-HEXAMETHYL-1-OXACYCLOTETRADECAN-2-ONE
  • 127183-36-2
  • 127183-39-5
  • 127183-41-9
  • 127183-43-1
  • 127183-44-2
  • 127183-48-6
  • 127183-49-7
  • 127183-50-0
  • 127183-51-1
  • 6-O-Methylerythromycin A (E)-9-(O-methyloxime); (9E)-6-O-Methylerythromycin 9-(O-methyloxime); Oxacyclotetradecane, erythromycin deriv.; Clarithromycin Imp. G (EP)